Acronym: BEBOP PMR
Polymyalgia rheumatica (PMR) is a rheumatic condition that primarily affects older people. Little is known about the prevalence of the condition or the care provided to those affected in Germany. The retrospective observational study „BEBOP PMR“ investigates how patients with PMR are treated in general practitioners’ practices within the FoPraNet-BW network, what symptoms they experience and which doctors they consult.
In retrospect, the research teams collected clinical data on patients whom they had treated for PMR in their practices.
54 of the study participants are female. The average age at the time of the initial diagnosis of PMR is 70 years. 23 % were treated exclusively at a GP practice, whilst 73 % also consulted other specialist departments (most commonly rheumatology, orthopaedics and neurology). 13 % were admitted to hospital due to PMR.
The most common symptoms include shoulder and hip pain. In addition, 61 % of those affected show signs of an atypical course of the disease, such as fatigue, night sweats or weight loss. Information on laboratory test results at the time of diagnosis cannot be fully determined from the retrospectively analysed healthcare data. 94 % of the participants receive glucocorticoids, often before or at the time of diagnosis. The initial dosage averages 29.5 mg of prednisolone equivalent.
The healthcare data analysed show that 54 % of those affected are female. The average age at the time of the initial diagnosis of polymyalgia rheumatica is 70 years. 23 % were treated exclusively at a GP practice, whilst 73 % also consulted other specialist departments, most commonly rheumatology, orthopaedics and neurology. 13 % were admitted to hospital due to PMR.
The most common symptoms include shoulder and hip pain. In addition, 61 % of those affected show signs of an atypical course of the disease, such as fatigue, night sweats or weight loss. Information on laboratory results at the time of diagnosis cannot be fully determined from the retrospectively analysed healthcare data. 94 % of patients are prescribed glucocorticoids, often before or at the time of diagnosis. The initial dosage averages 29.5 mg of prednisolone equivalent.